NEW YORK (GenomeWeb News) – Horizon Discovery said today it has received a share of a European Union Seventh Framework Programme grant totaling €5.75 million ($7.8 million) for work it will do on a project called "CV genes-at-target."

The grant was awarded to a consortium of research institutions and companies to study genomic risk loci for coronary artery disease and stroke in in vitro and in vivo settings and to determine whether they can serve as therapeutic targets.

Horizon did not specify how much of the grant it is receiving.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.